Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2001-06-08
2003-06-10
Prats, Francisco (Department: 1651)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S075000, C435S136000, C435S146000, C536S004100, C536S127000
Reexamination Certificate
active
06576446
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel process for producing a high-content product of 2-O-&agr;-D-glucopyranosyl-L-ascorbic acid (hereinafter abbreviated as “&agr;G-AA”, unless specified otherwise), a stabilized L-ascorbic acid.
2. Description of the Prior Art
As disclosed in Japanese Patent Kokai No. 183,492/91, &agr;G-AA is known to have the following satisfactory physicochemical properties:
(1) It is not directly reducible, but has outstandingly high stability, and, unlike L-ascorbic acid, it does not cause a Maillard reaction and unnecessary reaction even when in the presence of amino acids, peptides, proteins, lipids, saccharides, or physiologically active substances, but it stabilizes them;
(2) Upon hydrolysis, it forms L-ascorbic acid, then exhibits substantially the same reducing and anti-oxidation actions as L-ascorbic acid;
(3) It is easily hydrolyzed by in vivo enzymes into L-ascorbic acid and D-glucose to exhibit the physiological activities inherent to L-ascorbic acid, and is capable of enhancing the physiological properties of vitamins E and P when used in combination;
(4) It is highly safe because it is naturally formed in a slight amount though and, when orally taken, it is metabolized in vivo into L-ascorbic acid and a substance such as an &agr;-glucosyl saccharide compound;
(5) Although &agr;G-AA in a crystalline form is non- or substantially non-hygroscopic, it has a relatively-high solubility rate and solubility in water, and thus it can be advantageously used as a vitamin C-enriching agent, taste improver, acid-imparting agent, or stabilizer for vitamin preparations in the form of a powder, granule or tablet; and used in foods and beverages such as sand creams, chocolates, chewing gums, instant juices, and instant seasonings; and
(6) It has satisfactory handleability because &agr;G-AA in a crystalline form is non- or substantially non-hygroscopic and keeps its free-flowing ability without solidification during storage. As compared with &agr;G-AA in a non-crystalline form, &agr;G-AA in a crystal form can highly cut physical and labor costs required in its package, transportation, and storage.
&agr;G-AA is now widely used in a cosmetic field mainly and is expected for its explorative use in other various fields such as food products, pharmaceuticals, feeds, pet foods, and industrial materials.
As a representative example of industrial process for producing &agr;G-AA is, for example, a process as disclosed in Japanese Patent Kokai No. 183,492/91. The process, as shown in
FIG. 1
, comprises the steps of contacting a solution containing L-ascorbic acid and an a-glucosyl saccharide compound(s) with a saccharide-transferring enzyme or glucoamylase (EC 3.2.1.3) to form &agr;G-AA to obtain a solution comprising &agr;G-AA, intact L-ascorbic acid, &agr;-glucosyl saccharide compound(s) and other saccharides produced from the &agr;-glucosyl saccharide compound(s) filtering the resulting solution; removing minerals from the filtrate by subjecting the filtrate to column chromatography using a cation-exchange resin (H-form); subjecting the demineralized solution to column chromatography using an anion-exchange resin to adsorb &agr;G-AA and L-ascorbic acid on the anion-exchange resin; washing the anion-exchange resin with water to remove saccharides from the column; eluting the &agr;G-AA and the L-ascorbic acid from the anion-exchange resin; concentrating the eluate; subjecting the concentrate to column chromatography using a strong-acid cation exchange resin to fractionate into a fraction rich in &agr;G-AA and a fraction rich in L-ascorbic acid; and concentrating the former fraction into a high &agr;G-AA content product.
In the above column chromatography using an anion-exchange resin, &agr;G-AA and L-ascorbic acid are simultaneously desorbed from the resin, and this yields &agr;G-AA in a mixture form with L-ascorbic acid. To obtain a high &agr;G-AA content product, solutions containing &agr;G-AA and L-ascorbic acid should inevitably be first concentrated, then fractionated into a fraction rich in &agr;G-AA and a fraction rich in L-ascorbic acid
As described above, in conventional process for producing high &agr;G-AA content product, two steps of column chromatography using an anion-exchange resin and a cation-exchange resin are inevitably required, and the eluate from the column chromatography using the anion-exchange resin should be first concentrated before fed to column chromatography using the cation-exchange resin, and, as the demerits, these complicate the preparation of &agr;G-AA, lower the yield of high &agr;G-AA content products, and increase the production cost.
Under these circumstances, there has been in a great demand an industrial-scale production of high &agr;G-AA content products with relatively-high quality and satisfactory processibility, production cost, and yield.
SUMMARY OF THE INVENTION
The object of the present invention is to provide an industrial-scale production of high &agr;G-AA content products with relatively-high quality and satisfactory processibility, production cost, and yield. The term “high &agr;G-AA content product(s)” as referred to in the present invention means high &agr;G-AA content product(s) which contain(s) at least 80% (w/w) of &agr;G-AA (“% (w/w)” may be abbreviated as “%”, hereinafter) on a dry solid basis (d.s.b.), preferably, at least 90%, and which may have any form of a liquid, paste, solid or powder.
In view of the foregoing, the present inventors continued studies on a simpler process for producing high &agr;G-AA content products by contacting a solution containing &agr;G-AA and L-ascorbic acid with an ion-exchange resin packed in a column. As a result, they found that the object can be attained by using an anion-exchange resin as an ion-exchange resin to be packed in a column; allowing &agr;G-AA and L-ascorbic acid to adsorb on the anion resin; feeding to the column an aqueous solution, as an eluent, of an acid and/or a salt with a concentration of less than 0.5 N to fractionate into a fraction rich in &agr;G-AA and a fraction rich in L-ascorbic acid; and collecting the former fraction.
As shown in
FIG. 2
, the process for producing high &agr;G-AA content product according to the present invention is characterized in that it comprises the steps of allowing a saccharide-transferring enzyme with or without glucoamylase to act on a solution containing L-ascorbic acid and an &agr;-glucosyl saccharide compound(s) to obtain a solution containing &agr;G-AA, L-ascorbic acid, and saccharides; filtering the solution; demineralizing the filtrate; contacting the demineralized solution, as a material solution, with an anion-exchange resin packed in a column to adsorb on the resin &agr;G-AA and L-ascorbic acid; washing the resin with water to remove saccharides from the column; feeding an aqueous solution of an acid and/or a salt with a concentration of less than 0.5 N to fractionate a fraction rich in &agr;G-AA and a fraction rich in L-ascorbic acid; and concentrating the former fraction to obtain a high &agr;G-AA content product. According to the present invention, &agr;G-AA, and L-ascorbic acid can be separated by column chromatography using an anion-exchange resin, resulting in a cancellation of the column chromatography using a strong-acid cation exchange resin which is inevitably used in a conventional preparation as shown in FIG.
1
. As a result, relatively-high quality products rich in &agr;G-AA with advantageous processibility, economical viewpoint, and yield can be produced in an industrial scale.
REFERENCES:
patent: 5508391 (1996-04-01), Sakai et al.
patent: 0 425 066 (1990-03-01), None
patent: 183492/91 (1991-08-01), None
patent: 6 228183 (1994-08-01), None
Scopes, Protein Purification, Principles and Practice, Spring-Verlag, New York, pp. 113-126, 1987.
Miyake Toshio
Nishi Koichi
Yamasaki Hiroshi
Browdy and Neimark PLLC
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
Prats Francisco
LandOfFree
Process for producing high... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing high..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing high... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3158362